Skip to main content

Cardiac Assist Devices Market is Expected to Grow Drastically, Assured By Experts From 2023 To 2028

 


Market Overview:

Cardiac assist devices are medical devices that have been specially designed for the patients suffering from cardiomyopathy, myelopathy, congenital heart disease, or peripheral arterial disease. These devices have been greatly useful in the treatment of patients who are unable to pump blood efficiently throughout the body due to a cardiac disorder or due to any other cardiac problem. Cardiac assist devices (CAD) are blood pumps that support the circulatory functions of severely ill cardiac patients. These pumps work along with the heart to improve the pumping efficiency and maintain optimum blood flow throughout the body. These devices are used to treat end-stage heart failure and are determined by the needs of the individual.

Competitive Landscape:

Major players operating in the global cardiacassist devices market are ABIOMED, Heart Ware International, Thoratec Corporation, Teleflex Incorporated, Berlin Heart GmbH, MAQUET GmbH & Co., and SynCardia Systems, Inc., among others.

Key Market Drivers:

High prevalence of cardiovascular diseases (CVDs) around the world is expected to aid in the growth of the cardiac assist devices market during the forecast period. For instance, as per the World Health Organization (WHO), cardiovascular diseases (CVDs) are one of the leading cause of death worldwide, taking an estimated 17.9 million lives each year.

Moreover, increasing adoption of cardiac assist devices in hospitals and homecare is expected to augment the growth of the cardiac assist devices market. For instance, in June 2021, Abbott announced the company has capacity and supply to effectively support the growing demand for mechanical circulatory support (MCS) devices for the effective treatment of advanced heart failure. Abbott is also supporting training and education programs for physicians who will now be offering Abbott's HeartMate 3 heart pumps to their patients.

 

Comments

Popular posts from this blog

The Global Autoclave Equipment Market Continues To Grow Owing To the Rising Demand from Healthcare Sectors for Sterilizing Medical Equipment to Ensure the Safety of the Post-Surgical Period

  Autoclave equipment is the most popular sterilization method in the industry and is used for many applications including the manufacture of food products. It is widely used in the foodservice industry to sterilize and cleanse equipment used in the process of preparing and serving food. The autoclave is the abbreviated form of autolysis which means oxidation. Autoclaves have various parts including an electric motor, a condenser, and a burner. Autoclave equipment includes vials for sealing the autoclave, a glass or plastic container that has been lined with wax or plastic, and the appropriate autoclave equipment accessories such thermometer for measuring the temperature of the autoclave. All modern steam sterilizing equipment & autoclave machines provide a much-refined workflow experience, which makes you reconsider whether or not steam sterilizing is all it can be. A wide range of sterilization methods is used for sterilizing your medical and laboratory specimen so the right ...

Biologics Market Increasing Prevalence of Chronic Diseases to Augment Growth of the market

  A  biologic  drug ( biologics ) is a product that is produced from living organisms or contains components of living organisms.  Biologic  drugs are widely used to prevent, diagnose, treat, or cure a variety of diseases, including infectious diseases, autoimmune disorders, chronic kidney disease, and cancer. Market Dynamics In the recent past, several novel biopharmaceutical products were approved by major regulatory bodies and major players in the market have launched various novel and innovative biopharmaceutical products. Rapid approvals and launches of novel products in the market are expected to be major drivers for growth of the biologicsmarket . 

Treprostinil Drugs Market - High Prevalence of Pulmonary Arterial Hypertension and R&D of New Formulations of Treprostinil to Augment Growth of market

  Treprostinil is an antihypertensive agent used to treat patients with pulmonary arterial hypertension. It can also be used in the treatment of Degos disease, an extremely rare disorder in which small and medium sized arteries become blocked (occlusive arteriopathy), restricting the flow of blood to affected areas. Market Dynamics High prevalence of pulmonary arterial hypertension is expected to propel growth of the treprostinil drugs market . For instance, according to the study, ‘High Geographic Prevalence of Pulmonary Artery Hypertension: Associations with Ethnicity, Drug Use, and Altitude’, published in February 2020, in the journal Pulmonary Circulation, the overall pulmonary arterial hypertension incidence was 14 cases per million and the annual period prevalence of pulmonary arterial hypertension was 93 cases per million. Decline in new prescriptions for treprostinil-based products is expected to hinder growth of the treprostinil drugs market. For instance, United The...